# ObjectiveHealth

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/objectivehealth

- Industry: Healthcare
- Headquarters: Franklin, US
- Website: www.objective.health/
- Total disclosed funding: $21M
- Latest round: Series C (Nov 10, 2022)
- Investors on record: 4

## About

Established in 2018 and based in Tennessee, US, ObjectiveHealth F.K.A ObjectiveGI, Inc. provides a platform for clinical research to improve patients. The company was co-founded by Colleen Hoke (CEO) and Don Lazas (Chief Medical Officer). In January 2024, Frist Cressey Ventures invested in ObjectiveHealth by Vitruvian Partners.

 The company offers tools and staff which is required for conducting clinical trials. The firm provides its services to sponsors, physicians, community health centers, and patients. The main focus of the firm is gastroenterology, dermatology, urology, oncology, biomarker, and metabolism disorders. 

 The January 2024 investment may enable ObjectiveHealth to enhance its management while maintaining its development.

## Funding rounds

- Series C, Nov 10, 2022, $7M — BIP Ventures, Frist Cressey Ventures
- Series B, Mar 25, 2021, $7M — BIP Ventures, Frist Cressey Ventures
- Series A, Dec 9, 2019, $6.6M — NueCura Partners, Frist Cressey Ventures, Sprim Ventures

## Investors

- NueCura Partners — Series A
- Frist Cressey Ventures (https://capitalatlas.ai/funds/frist-cressey-ventures) — Series A, Series B, Series C
- Sprim Ventures (https://capitalatlas.ai/funds/sprim-ventures) — Series A
- BIP Ventures (https://capitalatlas.ai/funds/bip-ventures) — Series B, Series C